Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease

Omentin inhibits osteoblastic differentiation of calcifying vascular smooth muscle cells through the PI3K/Akt pathway

(2010) Xin-Yun Duan et al.   AMINO ACIDS

Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes

(2010) Hong-Yan Pan et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Elevated serum chemerin concentrations are associated with renal dysfunction in type 2 diabetic patients

(2010) Wenchao Hu et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Inflammation, a Link between Obesity and Cardiovascular Disease

(2010) Zhaoxia Wang et al.   MEDIATORS OF INFLAMMATION

Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes

(2010) Anke Tönjes et al.   PLoS One

Chemerin: at the crossroads of inflammation and obesity

(2010) Matthew C. Ernst et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging study

(2009) Karsten Müssig et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Interleukin-1ß induces the novel adipokine chemerin in adipocytes in vitro

(2009) Susan Kralisch et al.   REGULATORY PEPTIDES

Adipokines: The missing link between insulin resistance and obesity

(2008) B. Antuna-Puente et al.   DIABETES & METABOLISM

Decreased plasma omentin-1 levels in Type 1 diabetes mellitus

(2008) B. K. Tan et al.   DIABETIC MEDICINE

Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes

(2008) Michiko Takahashi et al.   FEBS LETTERS